Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'neuropeptide y 13 36 porcine'

Search results for: 'neuropeptide y 13 36 porcine'

Items 11-20 of 52

Page
per page
  1. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     21 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  2. MLN8054
    A4114 MLN8054
    Target: Aurora Kinases
    Summary: Aurora A inhibitor
      insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
  3. Hesperadin
    A4118 Hesperadin
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor
      ≥25.85 mg/mL
  4. Tolcapone
    A4383 Tolcapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
      insoluble in H2O; ≥12 mg/mL
  5. Lithium carbonate
    B7705 Lithium carbonate
    Target: Na /K ATPases
    Summary: Na+/K+ ATPase pump inhibitor
      insoluble in EtOH; ≥2.74 mg/mL
  6. LY 294002
    A8250 LY 294002
     16 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor
  7. Torin 1
    A8312 Torin 1
     7 Citation
    Target: mTOR
    Summary: MTOR inhibitor,potent and selective
  8. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    Target: P-glycoprotein (P-gp)
    Summary: Pgp (P-glycoprotein) inhibitor
      insoluble in EtOH; ≥17.1 mg/mL
  9. Faropenem daloxate
    A3411 Faropenem daloxate
    Summary: Oral penem,beta-lactam antibiotic
      Soluble in DMSO
  10. GSK2606414
    A3448 GSK2606414
     4 Citation
    Summary: PERK inhibitor,potent and selective
      ≥22.57 mg/mL

Items 11-20 of 52

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
Target
  1. Histone Deacetylases (HDACs) 2item
  2. Akt 1 item
  3. PI3K 5item
  4. CXCR 1 item
  5. Raf 2item
  6. Aurora Kinases 3item
  7. mTOR 2item
  8. MMP 3item
  9. Androgen Receptors 1 item
  10. FLT3 2item
  11. LPA Receptors 1 item
  12. P-glycoprotein (P-gp) 1 item
  13. PLK 1 item
  14. ULK1 1 item
  15. Eph Receptors 1 item
  16. VEGFR 4item
  17. PDGFR 4item
  18. c-Kit 2item
  19. RET 1 item
  20. Phosphodiesterases (PDEs) 1 item
  21. Bcr-Abl 2item
  22. FGFR 2item
  23. Voltage-gated Sodium (NaV) Channels 2item
  24. Src 1 item
  25. ROCK 2item
  26. PAK 1 item
  27. p300 1 item
  28. DNA-PK 3item
  29. HSP90 1 item
  30. eIF4E/eIF3G interaction 1 item
  31. RAD51 1 item
  32. LRRK2 1 item
  33. Voltage-gated Calcium Channels (CaV) 1 item
  34. Melanocortin (MC) Receptors 1 item
  35. HIV-1 gp120 1 item
  36. Glutamate (Metabotropic) Group I Receptors 1 item
  37. Synthases/Synthetases 1 item
  38. NPY Receptors 1 item
  39. Na /K ATPases 1 item
  40. P110 1 item
  41. Hck 1 item
  42. Catechol O-Methyltransferase (COMT) 1 item
  43. angiogenesis 1 item
  44. Histone Acetyltransferases (HATs) 1 item
  45. NOD1 1 item
  46. DCLK2 1 item
  47. gp120/CD4 1 item
  48. ATM 1 item
Reported Experiments
  1. Animal Experiments 41item
  2. Cell Experiments 34item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 5item
  5. Cancer 30item
  6. Chronic Lymphocytic Leukemia 2item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 2item
  11. Colorectal Cancer 3item
  12. Glioblastoma 3item
  13. Glioma 3item
  14. HIV 2item
  15. Leukemia 3item
  16. Lung Cancer 4item
  17. Lymphoma 1 item
  18. Melanoma 1 item
  19. Multiple Myeloma 3item
  20. Myelofibrosis 1 item
  21. Neuroblastoma 3item
  22. Neurocognitive Disorders 1 item
  23. Non-small Cell Lung Carcinoma 1 item
  24. Obsessive-Compulsive Disorder 1 item
  25. Osteoporosis 1 item
  26. Ovarian Cancer 2item
  27. Pancreatic Cancer 3item
  28. Prostate Cancer 4item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cancer 1 item
  31. Schizophrenia 1 item
  32. Soft Tissue Sarcoma 1 item
  33. Thyroid Cancer 1 item